Trastuzumab Deruxtecan 100mg Injection — HER2-Targeted Antibody-Drug Conjugate for HER2-Positive and HER2-Low Breast Cancer, Gastric Cancer and HER2-Mutant NSCLC
Ribociclib 200mg Film-Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer With Proven Overall Survival Benefit Across Pre/Perimenopausal and Postmenopausal Women
Palbociclib 75mg, 100mg, 125mg Capsules — First-in-Class CDK4/6 Inhibitor for HR-Positive HER2-Negative Advanced and Metastatic Breast Cancer in Combination With Endocrine Therapy
Alpelisib 150mg, 200mg, 250mg+50mg Film-Coated Tablets — PI3Kα-Selective Inhibitor for HR-Positive HER2-Negative PIK3CA-Mutated Advanced or Metastatic Breast Cancer in Combination With Fulvestrant
Abemaciclib 50mg, 100mg, 150mg Film Coated Tablets — CDK4/6 Inhibitor for HR-Positive HER2-Negative Breast Cancer in Combination With Endocrine Therapy and as Monotherapy
